---
title: O.C.G.A. § 33-53-2. Conditions of coverage.
collection: code
id: 33-53-2
cite_as: O.C.G.A. § 33-53-2 (2025)
canonical_url: https://georgiacommons.org/code/33-53-2
md_url: https://georgiacommons.org/code/33-53-2.md
text_url: https://georgiacommons.org/code/33-53-2/text
source_url: https://www.legis.ga.gov/api/document/docs/default-source/joint-features-document-library/t33-ch23-65-(v25)-2020-pdf.pdf?sfvrsn=68297_0#page=987
date: 2025
status: active
corpus_version: 2025-supplement-89aa39ab3c68
license: CC0-1.0
publisher: Georgia Commons, an independent project of Georgia Civic Data. Not the State of Georgia. Not legal advice.
up: https://georgiacommons.org/code/33-53.md
previous: https://georgiacommons.org/code/33-53-1.md
next: https://georgiacommons.org/code/33-53-3.md
index: https://georgiacommons.org/code/index.md
version: the only printed version
in_force: true
current_through: Including Acts of the 2025 Regular Session of the General Assembly
heading_path: INSURANCE / COVERAGE FOR CERTAIN TYPES OF ANTI-CANCER DRUG THERAPY
---

# O.C.G.A. § 33-53-2. Conditions of coverage.

An insurance policy that provides coverage for drugs may not exclude coverage of a covered drug on the grounds that the drug has not been approved by the federal Food and Drug Administration for the particular indication if any of the following conditions are met:

(1) The drug is recognized for treatment of the indication in at least one standard reference compendium;

(2) The drug is recommended for that particular type of cancer and found to be safe and effective in formal clinical studies, the results of which have been published in a peer reviewed professional medical journal published in either the United States or Great Britain.

## History

Code 1981, § 33-53-2, enacted by Ga. L. 1993, p. 539, § 1.

## Code Commission Notes

Pursuant to Code Section 28-9-5, in 1993, ‘‘peer reviewed’’ was substituted for ‘‘peer-reviewed’’ in paragraph (2).